A237690 Stock Overview
Provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 4/6 |
Past Performance | 2/6 |
Financial Health | 4/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
ST Pharm Co.,Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₩94,300.00 |
52 Week High | ₩112,700.00 |
52 Week Low | ₩59,900.00 |
Beta | 0.66 |
11 Month Change | 5.01% |
3 Month Change | 6.19% |
1 Year Change | 25.07% |
33 Year Change | -18.92% |
5 Year Change | 603.73% |
Change since IPO | 93.24% |
Recent News & Updates
Is ST Pharm Co.,Ltd. (KOSDAQ:237690) Trading At A 41% Discount?
May 09Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem
Mar 22Recent updates
Is ST Pharm Co.,Ltd. (KOSDAQ:237690) Trading At A 41% Discount?
May 09Why ST PharmLtd's (KOSDAQ:237690) Earnings Are Better Than They Seem
Mar 22ST Pharm Co.,Ltd. (KOSDAQ:237690) Stock Rockets 54% As Investors Are Less Pessimistic Than Expected
Mar 18Investors Who Bought ST PharmLtd (KOSDAQ:237690) Shares A Year Ago Are Now Up 221%
Mar 16Calculating The Fair Value Of ST Pharm Co.,Ltd. (KOSDAQ:237690)
Jan 22What Type Of Shareholders Own The Most Number of ST Pharm Co.,Ltd. (KOSDAQ:237690) Shares?
Dec 23Health Check: How Prudently Does ST PharmLtd (KOSDAQ:237690) Use Debt?
Nov 26Shareholder Returns
A237690 | KR Pharmaceuticals | KR Market | |
---|---|---|---|
7D | 2.8% | 2.4% | -1.4% |
1Y | 25.1% | 12.4% | 0.1% |
Return vs Industry: A237690 exceeded the KR Pharmaceuticals industry which returned 12.4% over the past year.
Return vs Market: A237690 exceeded the KR Market which returned 0.1% over the past year.
Price Volatility
A237690 volatility | |
---|---|
A237690 Average Weekly Movement | 9.2% |
Pharmaceuticals Industry Average Movement | 4.2% |
Market Average Movement | 5.0% |
10% most volatile stocks in KR Market | 11.1% |
10% least volatile stocks in KR Market | 2.2% |
Stable Share Price: A237690 has not had significant price volatility in the past 3 months.
Volatility Over Time: A237690's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of KR stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1983 | 627 | Peter Kim | www.stpharm.co.kr |
ST Pharm Co.,Ltd., provides custom manufacturing services for active pharmaceutical ingredient and intermediates in South Korea and internationally. The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics. It also offers pre-clinical and bioanalytical R and D solutions.
ST Pharm Co.,Ltd. Fundamentals Summary
A237690 fundamental statistics | |
---|---|
Market cap | ₩1.86t |
Earnings (TTM) | ₩22.03b |
Revenue (TTM) | ₩286.07b |
84.3x
P/E Ratio6.5x
P/S RatioIs A237690 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
A237690 income statement (TTM) | |
---|---|
Revenue | ₩286.07b |
Cost of Revenue | ₩182.47b |
Gross Profit | ₩103.60b |
Other Expenses | ₩81.57b |
Earnings | ₩22.03b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | 1.12k |
Gross Margin | 36.22% |
Net Profit Margin | 7.70% |
Debt/Equity Ratio | 46.2% |
How did A237690 perform over the long term?
See historical performance and comparison